Operating Expenses Cambiamento Data
Acadia Pharmaceuticals USD 232.19M 7.16M 2025-06
Adcock Ingram Holdings ZAR 4.23B 196.72M 2024-12
Agios Pharmaceuticals USD 139.51M 24.16M 2025-06
Alnylam Pharmaceuticals USD 789.89M 213.78M 2025-06
Amgen USD 6.52B 337M 2025-06
Arrowhead Research USD 193.32M 31.81M 2025-06
Biogen USD 1.79B 326.1M 2025-06
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Celltrion KRW 718.99B 24.68B 2025-06
Cspc Pharmaceutical CNY 5.22B 248.9M 2025-03
Dianthus Therapeutics USD 35.12M 1.88M 2025-06
Divis Laboratories Ltd 17.93B 130M 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
GlaxoSmithKline GBP 5.96B 663M 2025-06
Incyte USD 904.7M 56.97M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
Kangmei Pharma CNY 1.25B 35.75M 2025-06
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 132.33M 179.02M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Moderna USD 1.04B 113M 2025-06
Organigram Holdings CAD 72.9M 18.86M 2025-06
Pharma Mar EUR 32.29M 9.66M 2025-06
Qiagen NV USD 397.57M 39.27M 2025-06
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Sarepta Therapeutics USD 495.51M 549.73M 2025-06
Sartorius EUR 722.5M 23.1M 2025-06
Sino Biopharmaceutical CNY 11.66B 352.34M 2024-12
Tilray USD 253.17M 16.55M 2024-11
Ultragenyx Pharmaceutical USD 274.38M 7.85M 2025-06
United Therapeutics USD 521.7M 110.1M 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06
Zz Pientze Pharmaceu 1.68B 272.39M 2025-06


Moderna Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.